About Immix Biopharma, Inc. 
Immix Biopharma, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 5 Schemes (3.29%)
Foreign Institutions
Held by 5 Foreign Institutions (1.59%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2025)
Net Profit:
-8 Million
Pharmaceuticals & Biotechnology
USD 258 Million ()
NA (Loss Making)
NA
0.00%
-1.91
-285.09%
31.18






